Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX1PV5
|
||||
| Drug Name |
4-Methoxy-N-{1-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-3-methyl-butyl}-benzamide
|
||||
| Synonyms |
CHEMBL59605
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H31N3O4
|
||||
| Canonical SMILES |
COc1ccc(NCCNC(=O)[C@H](CC(C)C)NC(=O)c2ccc(OC)cc2)cc1
|
||||
| InChI |
InChI=1S/C23H31N3O4/c1-16(2)15-21(26-22(27)17-5-9-19(29-3)10-6-17)23(28)25-14-13-24-18-7-11-20(30-4)12-8-18/h5-12,16,21,24H,13-15H2,1-4H3,(H,25,28)(H,26,27)/t21-/m0/s1
|
||||
| InChIKey |
DUYXXIKSTBHSGJ-NRFANRHFSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.